Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier to Improve Lung Cancer Diagnosis
April 15, 2015Veracyte launches Percepta™ Bronchial Genomic Classifier, a new genomic test for lung cancer that is designed to resolve ambiguity in lung cancer diagnosis. Veracyte will soon begin testing patient samples in its CLIA-certified laboratory.
More »
Veracyte and GE Announce Research Collaboration
April 14, 2015Veracyte and GE today announced a research collaboration to explore combining Veracyte's genomic technology with GE Healthcare's digital imaging technology in order develop new solutions that can improve disease diagnosis.
More »
Alimera Sciences' ILUVIEN® Receives 17th European Marketing Authorization; Completing Second Wave Of Country Approvals
April 14, 2015Alimera Sciences receives marketing authorization for ILUVIEN® by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland for the treatment of vision impairment associated with chronic diabetic macular edema (DME
More »